Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Drug Discovery. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase method for EGFR inhibitors. High purity, scalable route for anticancer drug discovery intermediates.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Patent CN107879989B details a robust synthetic route for bioactive benzodiazepines with antitumor activity, offering scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN116655503B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable methods.
Patent CN111087344A discloses a green synthesis for diaziridine-amino acid conjugates. This report analyzes the scalable route for high-purity pharmaceutical intermediates.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN115215783B reveals high-yield copper catalysis for chiral oxindoles. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110294708B details a metal-free synthesis of trifluoroethylselenophenanthridine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN114644629B discloses a green, metal-free synthesis of [1,2,4]triazolo[1,5-a]pyridines. This method offers significant cost reduction in API manufacturing and scalable production capabilities.
Discover metal-free pyrazole synthesis with 77-99% yield. Eliminate catalyst costs, simplify purification, and ensure GMP-compliant production for your drug development.
Discover how palladium-catalyzed 3-arylquinoline-2(1H) ketone synthesis with broad functional group tolerance reduces production costs and supply chain risks for pharmaceutical intermediates.
Solve 5-maleimide chromone synthesis challenges with air-stable, high-yield ruthenium catalysis. Reduce costs & scale efficiently for drug development.
Overcome high costs and harsh conditions in 3-amino-2-indolone synthesis. This I2-H2O2 room-temperature method offers 80-90% yields, eliminating metal catalysts and reducing production risks for pharma R&D and procurement.
Discover a cost-effective, high-yield synthesis of 3-arylquinoline-2(1H) ketone derivatives using palladium-catalyzed aminocarbonylation. Ideal for API production with broad functional group tolerance and scalable to 100 MT/yr.
Discover how palladium-catalyzed carbonylation with CO substitute enables efficient indolo[2,1a]isoquinoline production. Reduce costs, improve scalability for drug development.
Discover a cost-effective, metal-free synthesis method for trifluoromethyl-1,2,4-triazine compounds. Eliminate heavy metal catalysts and nitrogen protection to reduce production costs and supply chain risks.
Discover a cost-effective, high-yield route for indolo[2,1a]isoquinoline synthesis. Our CDMO expertise ensures scalable production with 99%+ purity, reducing your supply chain risks.
Solve azacyclooctanofuranone synthesis challenges with iron-catalyzed one-pot method. Reduce costs, improve yield, and ensure green production for pharma R&D and procurement teams.
Discover efficient Pd-catalyzed carbonylation for indolo[2,1a]isoquinoline synthesis. Reduce costs, improve safety, and ensure supply chain stability for pharma intermediates.